Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019

Objective To analyze the epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Methods Based on data from the Global Burden of Disease 2019 survey (GBD 2019), we used incidence, mortality, disability-adjusted life years (DALY), years of life lost (YLL) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Wen-Tao WU, Da-Ning LI, Shuai ZHENG, Feng-Shuo XU, Di-Di HAN, Jun LYU
Format: Article
Language:zho
Published: Editorial Office of New Medicine 2021-12-01
Series:Yixue xinzhi zazhi
Subjects:
Online Access:https://yxxz.whuznhmedj.com/storage/attach/2112/T8eHnfu7MhEC5IC1zytzDnsGm3s7Qly9vTjvWSTI.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850059851019845632
author Wen-Tao WU
Da-Ning LI
Shuai ZHENG
Feng-Shuo XU
Di-Di HAN
Jun LYU
author_facet Wen-Tao WU
Da-Ning LI
Shuai ZHENG
Feng-Shuo XU
Di-Di HAN
Jun LYU
author_sort Wen-Tao WU
collection DOAJ
description Objective To analyze the epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Methods Based on data from the Global Burden of Disease 2019 survey (GBD 2019), we used incidence, mortality, disability-adjusted life years (DALY), years of life lost (YLL) and years lived with disability (YLD) and their standardized rates to analyze the epidemic trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Results From 1990 to 2019, the number of new cases of Hodgkin's lymphoma in China increased from 6,600 to 9,500, an increase of 42.68%, and the overall standardized incidence rate decreased from 0.65/100,000 to 0.57/100,000, a decrease of 11.12%, but it has rebounded since 2006. The number of deaths and standardized mortality rate decreased by 45.30% and 72.00%, respectively. The standardized rate of YLD increased by 66.77%, while standard-ized rates of DALY and YLL showed a decreasing trend of 73.31% and 74.82%, respectively. The incidence, mortality and DALY rates of different genders in-creased with age, but the incidence, mortality and DALY rates of males were higher than those of females. Conclusion From 1990 to 2019, the incidence rate of Hodgkin's lymphoma in China first decreased and then increased, the mortality rate and DALY rate showed a decreasing trend. Men and the elderly remain at high risk of the current disease burden of Hodgkin's lymphoma.
format Article
id doaj-art-5058ebd79c92434a9fd0741e09dca36a
institution DOAJ
issn 1004-5511
language zho
publishDate 2021-12-01
publisher Editorial Office of New Medicine
record_format Article
series Yixue xinzhi zazhi
spelling doaj-art-5058ebd79c92434a9fd0741e09dca36a2025-08-20T02:50:45ZzhoEditorial Office of New MedicineYixue xinzhi zazhi1004-55112021-12-0131643344010.12173/j.issn.1004-5511.2021080296287Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019Wen-Tao WUDa-Ning LIShuai ZHENGFeng-Shuo XUDi-Di HANJun LYUObjective To analyze the epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Methods Based on data from the Global Burden of Disease 2019 survey (GBD 2019), we used incidence, mortality, disability-adjusted life years (DALY), years of life lost (YLL) and years lived with disability (YLD) and their standardized rates to analyze the epidemic trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019. Results From 1990 to 2019, the number of new cases of Hodgkin's lymphoma in China increased from 6,600 to 9,500, an increase of 42.68%, and the overall standardized incidence rate decreased from 0.65/100,000 to 0.57/100,000, a decrease of 11.12%, but it has rebounded since 2006. The number of deaths and standardized mortality rate decreased by 45.30% and 72.00%, respectively. The standardized rate of YLD increased by 66.77%, while standard-ized rates of DALY and YLL showed a decreasing trend of 73.31% and 74.82%, respectively. The incidence, mortality and DALY rates of different genders in-creased with age, but the incidence, mortality and DALY rates of males were higher than those of females. Conclusion From 1990 to 2019, the incidence rate of Hodgkin's lymphoma in China first decreased and then increased, the mortality rate and DALY rate showed a decreasing trend. Men and the elderly remain at high risk of the current disease burden of Hodgkin's lymphoma.https://yxxz.whuznhmedj.com/storage/attach/2112/T8eHnfu7MhEC5IC1zytzDnsGm3s7Qly9vTjvWSTI.pdfhodgkin's lymphoma disease burden disability-adjusted life year incidence mortality
spellingShingle Wen-Tao WU
Da-Ning LI
Shuai ZHENG
Feng-Shuo XU
Di-Di HAN
Jun LYU
Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
Yixue xinzhi zazhi
hodgkin's lymphoma
disease burden
disability-adjusted life year
incidence
mortality
title Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
title_full Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
title_fullStr Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
title_full_unstemmed Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
title_short Epidemiological trends and disease burden of Hodgkin's lymphoma in China from 1990 to 2019
title_sort epidemiological trends and disease burden of hodgkin s lymphoma in china from 1990 to 2019
topic hodgkin's lymphoma
disease burden
disability-adjusted life year
incidence
mortality
url https://yxxz.whuznhmedj.com/storage/attach/2112/T8eHnfu7MhEC5IC1zytzDnsGm3s7Qly9vTjvWSTI.pdf
work_keys_str_mv AT wentaowu epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019
AT daningli epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019
AT shuaizheng epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019
AT fengshuoxu epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019
AT didihan epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019
AT junlyu epidemiologicaltrendsanddiseaseburdenofhodgkinslymphomainchinafrom1990to2019